TY - JOUR
T1 - Autologous stem cell transplant in 716 patients with multiple myeloma
T2 - Low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
AU - Gertz, Morie A.
AU - Ansell, Stephen M.
AU - Dingli, David
AU - Dispenzieri, Angela
AU - Buadi, Francis K.
AU - Elliott, Michelle A.
AU - Gastineau, Dennis A.
AU - Hayman, Suzanne R.
AU - Hogan, William J.
AU - Inwards, David J.
AU - Johnston, Patrick B.
AU - Kumar, Shaji
AU - Lacy, Martha Q.
AU - Leung, Nelson
AU - Micallef, Ivana N.M.
AU - Porrata, Luis F.
AU - Schafer, Barbara A.
AU - Wolf, Robert C.
AU - Litzow, Mark R.
PY - 2008/10
Y1 - 2008/10
N2 - We report on the feasibility of outpatient transplant in 716 patients undergoing autologous stem cell transplant for multiple myeloma at Mayo Clinic's site in Rochester, MN, from January 1, 2000, through October 31, 2007. We also report on the development and effect of a multidisciplinary quality initiative implemented by the Mayo Clinic Blood and Marrow Transplant Program involving physicians, nurses, pharmacists, dietitians, and financial specialists for outpatient management of patients undergoing stem cell transplant. This approach uses an electronic ordering system for diagnostic tests and chemotherapy to minimize medical errors. Analysis of hospitalization trends since inception of the program showed that 278 (39%) of the 716 patients treated completed the transplant procedure as outpatients. The median duration of hospitalization for all patients was 4 days; age and serum creatinine levels were predictive of the need for and duration of hospitalization. We also assessed recent treatment-related mortality rates during a 33-month period after implementation of the program (between January 1, 2005, and October 1, 2007). The 100-day survival rate was 99.5% for patients with low-risk myeloma (transplant during first plateau; n=201) and 97.2% for patients with high-risk myeloma (refractory, relapsing or second or greater plateau; n=71). The overall 100-day survival rate was 98.9%. Our experience shows that outpatient transplant is feasible for all patients with multiple myeloma and results in shorter hospital stays and low treatment-related mortality rates.
AB - We report on the feasibility of outpatient transplant in 716 patients undergoing autologous stem cell transplant for multiple myeloma at Mayo Clinic's site in Rochester, MN, from January 1, 2000, through October 31, 2007. We also report on the development and effect of a multidisciplinary quality initiative implemented by the Mayo Clinic Blood and Marrow Transplant Program involving physicians, nurses, pharmacists, dietitians, and financial specialists for outpatient management of patients undergoing stem cell transplant. This approach uses an electronic ordering system for diagnostic tests and chemotherapy to minimize medical errors. Analysis of hospitalization trends since inception of the program showed that 278 (39%) of the 716 patients treated completed the transplant procedure as outpatients. The median duration of hospitalization for all patients was 4 days; age and serum creatinine levels were predictive of the need for and duration of hospitalization. We also assessed recent treatment-related mortality rates during a 33-month period after implementation of the program (between January 1, 2005, and October 1, 2007). The 100-day survival rate was 99.5% for patients with low-risk myeloma (transplant during first plateau; n=201) and 97.2% for patients with high-risk myeloma (refractory, relapsing or second or greater plateau; n=71). The overall 100-day survival rate was 98.9%. Our experience shows that outpatient transplant is feasible for all patients with multiple myeloma and results in shorter hospital stays and low treatment-related mortality rates.
UR - http://www.scopus.com/inward/record.url?scp=54049084554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=54049084554&partnerID=8YFLogxK
U2 - 10.4065/83.10.1131
DO - 10.4065/83.10.1131
M3 - Article
C2 - 18828972
AN - SCOPUS:54049084554
SN - 0025-6196
VL - 83
SP - 1131
EP - 1135
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 10
ER -